Chicago (May 3, 2016) – Brainlab, a global leader in medical technology, today announced that it has enrolled 11, to date, of the expected 30 hospitals and healthcare systems in the national Stereotactic Radiosurgery (SRS) Patient Registry. Launched in partnership with The American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO), the patient registry will gather important patient data, aiming to define national patterns of care in radiosurgery, with an eye to improving health care outcomes, supporting informed decision-making and potentially lowering the cost of care for patients.
To date, the SRS Patient Registry is gathering de-identified data on almost 400 patients at the diverse, high-volume enrolled facilities. The registry logs the de-identified SRS treatment information of patients affected by brain metastases, benign brain tumors and arteriovenous malformations (AVMs). The SRS patient registry is set to prospectively collect data from 30 of the best hospitals in the United States over a three-year period, and under the banner of quality, generate a large clinical database, unlike any other.
“This level of detailed patient data analysis can change the way we look at methods and patterns of care from a both a population database and personalized medicine perspective,” said Brian Kavanagh, MD, MPH, FASTRO, Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado. “The more patients we upload into the registry, the closer we can approach our ultimate goal of thoroughly understanding SRS best practices so that we can help improve patient outcomes.”
Brainlab, a major investor in and supporter of the SRS registry, transfers treatment and outcome information to the database through Quentry®, a web-based image sharing service, which employs advanced encryption and access-control technologies to ensure that all sensitive medical information is secure.
“Over the next two years, all 30 hospitals in the registry are expected to upload thousands more patients,” said Jason Sheehan, MD, PhD, FACS, Harrison Distinguished Teaching Professor & Vice Chair, Department of Neurological Surgery University of Virginia Health System. “In an era of evidence-based medicine, this SRS Registry offers the potential to provide concrete guidelines and process benchmarks that could change patient outcomes on a global scale.”
Current sites providing patient data via Brainlab Quentry:
By the end of the summer, four additional facilities are set to begin uploading data to the SRS Patient Registry:
“We are excited to see the SRS registry gaining momentum, as more data will empower healthcare providers and administrators at participating facilities to optimize patient care,” said Stefan Vilsmeier, CEO and Founder, Brainlab.
ASTRO and AANS lead the Scientific Advisory Committee charged with providing strategic oversight for the registry. Analysis of the de-identified patient data will be scientifically published, and the fully de-identified data elements will subsequently be made available in the public domain.
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 8,500 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the entire nervous system, including the spinal column, spinal cord, brain and peripheral nerves.
To learn more, visit www.aans.org.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in 1989, Brainlab has over 9,000 systems installed in about 100 countries. Brainlab employs 1,200 people in 19 offices worldwide, including 300 research & development engineers, who form a crucial part of the product development team.
To learn more, visit www.brainlab.com.